W Stuart Reynolds1, Casey Kowalik2, Joshua Cohn3, Melissa Kaufman2, Alan Wein4, Roger Dmochowski2, Stephen Bruehl5. 1. Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: w.stuart.reynolds@vumc.org. 2. Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee. 3. Department of Urology, Einstein Healthcare Network, Pennsylvania. 4. Division of Urology, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. 5. Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.
Abstract
PURPOSE: We sought to determine whether women with overactive bladder who required third line therapy would demonstrate greater central sensitization, indexed by temporal summation to heat pain stimuli, than those with overactive bladder. MATERIALS AND METHODS: We recruited 39 women with overactive bladder from the urology clinic who were planning to undergo interventional therapy for medication refractory overactive bladder with onabotulinumtoxinA bladder injection or sacral neuromodulation. We also recruited 55 women with overactive bladder who were newly seen at our urology clinic or who responded to advertisements for study participation. Participants underwent quantitative sensory testing using a thermal temporal summation protocol. The primary study outcome was the degree of temporal summation as reflected in the magnitude of positive slope of the line fit to the series of 10 stimuli at a 49C target temperature. We compared the degree of temporal summation between the study groups using linear regression. RESULTS: Women in the group undergoing third line therapy showed significantly higher standardized temporal summation slopes than those in the nontreatment group (β = 1.57, 95% CI 0.18-2.96, t = 2.25, p = 0.027). On exploratory analyses a history of incontinence surgery or hysterectomy was associated with significantly greater temporal summation. CONCLUSIONS: In this study the degree of temporal summation was elevated in women undergoing third line overactive bladder therapy compared to women with overactive bladder who were not undergoing that therapy. These findings suggest there may be pathophysiological differences, specifically in afferent nerve function and processing, in some women with overactive bladder.
PURPOSE: We sought to determine whether women with overactive bladder who required third line therapy would demonstrate greater central sensitization, indexed by temporal summation to heat pain stimuli, than those with overactive bladder. MATERIALS AND METHODS: We recruited 39 women with overactive bladder from the urology clinic who were planning to undergo interventional therapy for medication refractory overactive bladder with onabotulinumtoxinA bladder injection or sacral neuromodulation. We also recruited 55 women with overactive bladder who were newly seen at our urology clinic or who responded to advertisements for study participation. Participants underwent quantitative sensory testing using a thermal temporal summation protocol. The primary study outcome was the degree of temporal summation as reflected in the magnitude of positive slope of the line fit to the series of 10 stimuli at a 49C target temperature. We compared the degree of temporal summation between the study groups using linear regression. RESULTS:Women in the group undergoing third line therapy showed significantly higher standardized temporal summation slopes than those in the nontreatment group (β = 1.57, 95% CI 0.18-2.96, t = 2.25, p = 0.027). On exploratory analyses a history of incontinence surgery or hysterectomy was associated with significantly greater temporal summation. CONCLUSIONS: In this study the degree of temporal summation was elevated in women undergoing third line overactive bladder therapy compared to women with overactive bladder who were not undergoing that therapy. These findings suggest there may be pathophysiological differences, specifically in afferent nerve function and processing, in some women with overactive bladder.
Authors: William Stuart Reynolds; Elizabeth Timbrook Brown; Jill Danford; Melissa Kaufman; Alan Wein; Roger Dmochowski; Stephen Bruehl Journal: Neurourol Urodyn Date: 2016-07-19 Impact factor: 2.696
Authors: Sandra H Berry; Marc N Elliott; Marika Suttorp; Laura M Bogart; Michael A Stoto; Paul Eggers; Leroy Nyberg; J Quentin Clemens Journal: J Urol Date: 2011-06-16 Impact factor: 7.450
Authors: Frederick Wolfe; Daniel J Clauw; Mary-Ann Fitzcharles; Don L Goldenberg; Robert S Katz; Philip Mease; Anthony S Russell; I Jon Russell; John B Winfield; Muhammad B Yunus Journal: Arthritis Care Res (Hoboken) Date: 2010-05 Impact factor: 4.794
Authors: R B Lipton; D Dodick; R Sadovsky; K Kolodner; J Endicott; J Hettiarachchi; W Harrison Journal: Neurology Date: 2003-08-12 Impact factor: 9.910
Authors: Josue S Cardoso; Joseph L Riley; Toni Glover; Kimberly T Sibille; Emily J Bartley; Burel R Goodin; Hailey W Bulls; Matthew Herbert; Adriana S Addison; Roland Staud; David T Redden; Laurence A Bradley; Roger B Fillingim; Yenisel Cruz-Almeida Journal: Pain Date: 2016-09 Impact factor: 7.926
Authors: Steven E Harte; Jon Wiseman; Ying Wang; Abigail R Smith; Claire C Yang; Margaret Helmuth; Karl Kreder; Grant H Kruger; Brenda W Gillespie; Cindy Amundsen; Ziya Kirkali; H Henry Lai Journal: J Urol Date: 2022-08-25 Impact factor: 7.600
Authors: William Stuart Reynolds; Melissa R Kaufman; Stephen Bruehl; Roger R Dmochowski; Lindsey C McKernan Journal: Neurourol Urodyn Date: 2021-09-15 Impact factor: 2.367